THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES
IJRTI2010003
Volume 5, Issue 10
Page 17 - 22
October 2020
205,665 Downloads
PublishedOpen AccessResearch PaperTransparent Peer ReviewedCC BY 4.0
ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open
Paper Title
THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES
Authors
Zubiya Ahsan , Noopur Khare , Abhimanyu Kumar Jha
Keywords
DNMT, Docking, Cancer, DNA Methylation, DNMT1
Abstract
Cancer is the uncontrolled division of the cell. Cancer is mainly caused due to mutation and epigenetic changes. DNA methylation is catalyzed by DNA methyltransferases (DNMT), is a major epigenetic modification that modulates gene expression. DNMT1 inhibition is a current challenge in cancer therapy because of inhibition of tumor suppressor genes (TSG) by hypermethylation. Abnormal DNA methylation has key roles in the development and progression of diseases including cancer. Therefore, it is of interest to screen DNMT1 (PDB ID 4WXX) target protein which causes disease with a known ligand compound using computer-aided molecular docking tools. The DNMT1 (PDB ID 4WXX) was retrieved from Protein Data Bank followed by molecular docking of ligands like Luotonin C (CID:102369825),Nimbin (CID: 108058), 2 Aminobenzamide (CID: 6942) and Vasicine (CID: 667496). All the 4 known ligand compounds were analyzed for the interaction with the target. After virtual screening by PyRx and analysis of drug likeliness property with SwissADME, Luotonin C (with the binding free energy of -6.1 kcal/mol) was the only compound found to be suitable as a drug. Through AutoDock Vina and Biovia Discovery studio client 2020 software different poses of Luotonin C were analyzed and finally through structure visualization tool PyMol, the interaction between the DNMT1 and Luotonin C were analyzed. Hence, it can be concluded that Luotonin C may act as a promising drug for the treatment of cancer after in vitro and in vivo studies.
Choose the style your journal or department asks for, then copy it.
Every version below is generated from this paper's own record.
IJRTI — journal style
"THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.5, Issue 10, page no.17 - 22, October-2020, Available :https://ijrti.org/papers/IJRTI2010003.pdf
APA — 7th edition
Ahsan, Z., Khare, N., & Jha, A. K. (2020). THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES. International Journal for Research Trends and Innovation, 5(10), 17 - 22. https://ijrti.org/viewpaperforall.php?paper=IJRTI2010003
MLA — 9th edition
Ahsan, Zubiya, et al. "THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES." International Journal for Research Trends and Innovation, vol. 5, no. 10, 2020, pp. 17 - 22, https://ijrti.org/viewpaperforall.php?paper=IJRTI2010003.
Chicago — 17th, bibliography
Ahsan, Zubiya, Noopur Khare, and Abhimanyu Kumar Jha. "THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES." International Journal for Research Trends and Innovation 5, no. 10 (2020): 17 - 22. https://ijrti.org/viewpaperforall.php?paper=IJRTI2010003.
Harvard — author–date
Ahsan, Z., Khare, N. and Jha, A.K. (2020) 'THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES', International Journal for Research Trends and Innovation, 5(10), pp. 17 - 22. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2010003
IEEE — numbered reference
Z. Ahsan, N. Khare and A. K. Jha, "THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES," IJRTI, vol. 5, no. 10, pp. 17 - 22, Oct. 2020.
Vancouver — biomedical
Ahsan Z, Khare N, Jha AK. THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES. IJRTI. 2020 Oct;5(10):17 - 22.
AMA — 11th edition
Ahsan Z, Khare N, Jha AK. THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES. IJRTI. 2020;5(10):17 - 22. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2010003
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2010003,
author = {Zubiya Ahsan and Noopur Khare and Abhimanyu Kumar Jha},
title = {THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES},
journal = {International Journal for Research Trends and Innovation},
volume = {5},
number = {10},
pages = {17 - 22},
year = {2020},
month = {October},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2010003}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Ahsan, Zubiya
AU - Khare, Noopur
AU - Jha, Abhimanyu Kumar
TI - THE DISCOVERY OF POTENTIAL DNMT1 INHIBITORS: A COMBINATION OF VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 5
IS - 10
PY - 2020
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2010003
SP - 17
EP - 22
ER -
International Journal for Research Trends and InnovationPublished by IJRTI (JW Publication)
2456-3315ISSN
10.57Impact Factor
2016ESTD Year
OpenAccess
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.